• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗难治性重度抑郁症的透皮东莨菪碱

Transdermal Scopolamine for Treatment-Resistant Major Depressive Disorder.

作者信息

Liester Mitchell B, Shash Delia S

机构信息

Psychiatry, University of Colorado School of Medicine, Colorado Springs, USA.

Obstetrics and Gynecology, University of Arizona, Phoenix, USA.

出版信息

Cureus. 2024 Sep 2;16(9):e68447. doi: 10.7759/cureus.68447. eCollection 2024 Sep.

DOI:10.7759/cureus.68447
PMID:39360115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11446176/
Abstract

Conventional antidepressants are useful in the treatment of major depressive disorder (MDD) but are limited by their delayed onset of action and lack of adequate therapeutic response in approximately one-third of patients. This has led to a quest for faster-acting and more effective antidepressants. Scopolamine exhibits rapid antidepressant effects when administered intravenously. We report a case of a female with treatment-resistant depression (TRD) who responded to transdermal scopolamine. She had a rapid (within three days) and sustained (119 days) response to transdermal scopolamine. Further research into the use of transdermal scopolamine for the treatment of depression is recommended.

摘要

传统抗抑郁药对治疗重度抑郁症(MDD)有效,但受起效延迟限制,且约三分之一的患者缺乏足够的治疗反应。这促使人们寻求起效更快、更有效的抗抑郁药。静脉注射东莨菪碱时具有快速抗抑郁作用。我们报告一例难治性抑郁症(TRD)女性患者,其对透皮东莨菪碱有反应。她对透皮东莨菪碱有快速(三天内)且持续(119天)的反应。建议进一步研究透皮东莨菪碱在抑郁症治疗中的应用。

相似文献

1
Transdermal Scopolamine for Treatment-Resistant Major Depressive Disorder.用于治疗难治性重度抑郁症的透皮东莨菪碱
Cureus. 2024 Sep 2;16(9):e68447. doi: 10.7759/cureus.68447. eCollection 2024 Sep.
2
The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials.东莨菪碱作为重度抑郁症抗抑郁药的潜力:随机对照试验的系统评价
Biomedicines. 2023 Sep 26;11(10):2636. doi: 10.3390/biomedicines11102636.
3
Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.囊泡谷氨酸转运体 1(VGLUT1)介导的谷氨酸释放和膜 GluA1 激活参与了东莨菪碱在小鼠中快速抗抑郁样作用。
Neuropharmacology. 2018 Mar 15;131:209-222. doi: 10.1016/j.neuropharm.2017.12.028. Epub 2017 Dec 20.
4
Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.东莨菪碱对小鼠抗抑郁样特征相关机制的进一步评估
CNS Neurol Disord Drug Targets. 2017;16(4):492-500. doi: 10.2174/1871527316666170309142646.
5
Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder.杏仁核对基线时呈现的悲伤面孔刺激的反应可预测重度抑郁症患者接受东莨菪碱治疗的反应。
Psychiatry Res Neuroimaging. 2016 Aug 30;254:67-73. doi: 10.1016/j.pscychresns.2016.06.005. Epub 2016 Jun 20.
6
Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder.与抗抑郁药氯胺酮反应相关的神经生理变化在一项大 抑郁症中莨菪碱阴性试验中未观察到。
Int J Neuropsychopharmacol. 2019 Jan 1;22(1):10-18. doi: 10.1093/ijnp/pyy051.
7
[Interest of scopolamine as a treatment of major depressive disorder].[东莨菪碱作为重度抑郁症治疗方法的研究意义]
Encephale. 2016 Dec;42(6):568-573. doi: 10.1016/j.encep.2016.06.002. Epub 2016 Sep 9.
8
Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.视觉皮层情绪处理过程中的预处理神经活动对预测大 抑郁症患者东莨菪碱治疗反应的潜力。
JAMA Psychiatry. 2013 Mar;70(3):280-90. doi: 10.1001/2013.jamapsychiatry.60.
9
Involvement of muscarinic receptor mechanisms in antidepressant drug action.毒蕈碱受体机制在抗抑郁药物作用中的参与。
Adv Pharmacol. 2020;89:311-356. doi: 10.1016/bs.apha.2020.03.003. Epub 2020 May 5.
10
Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants.使用速效抗抑郁药预防难治性重度抑郁症的复发
Adv Pharmacol. 2020;89:237-259. doi: 10.1016/bs.apha.2020.05.002. Epub 2020 Jun 20.

本文引用的文献

1
Defining treatment-resistant depression.定义治疗抵抗性抑郁症。
Depress Anxiety. 2020 Feb;37(2):134-145. doi: 10.1002/da.22968. Epub 2019 Oct 22.
2
Neurochemical correlation between major depressive disorder and neurodegenerative diseases.重度抑郁症与神经退行性疾病的神经化学相关性。
Life Sci. 2016 Aug 1;158:121-9. doi: 10.1016/j.lfs.2016.06.027. Epub 2016 Jun 28.
3
Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors.东莨菪碱的快速抗抑郁作用:内侧前额叶皮层和M1型毒蕈碱型乙酰胆碱受体的作用
Neurobiol Dis. 2015 Oct;82:254-261. doi: 10.1016/j.nbd.2015.06.012. Epub 2015 Jun 21.
4
Scopolamine patch withdrawal syndrome.东莨菪碱贴片戒断综合征
Hosp Pharm. 2014 Mar;49(3):218-20. doi: 10.1310/hpj4903-218.
5
New paradigms for treatment-resistant depression.治疗抵抗性抑郁症的新范式。
Ann N Y Acad Sci. 2013 Jul;1292:21-31. doi: 10.1111/nyas.12223.
6
Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.东莨菪碱可迅速增强哺乳动物雷帕霉素靶蛋白复合物 1 信号、突触形成和抗抑郁行为反应。
Biol Psychiatry. 2013 Nov 15;74(10):742-9. doi: 10.1016/j.biopsych.2013.04.025. Epub 2013 Jun 14.
7
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.抗胆碱能药物东莨菪碱的抗抑郁疗效:一项随机、安慰剂对照临床试验。
Arch Gen Psychiatry. 2006 Oct;63(10):1121-9. doi: 10.1001/archpsyc.63.10.1121.
8
New approaches to antidepressant drug discovery: beyond monoamines.抗抑郁药物研发的新方法:超越单胺类
Nat Rev Neurosci. 2006 Feb;7(2):137-51. doi: 10.1038/nrn1846.
9
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.东莨菪碱临床应用中的药代动力学与药效学
Ther Drug Monit. 2005 Oct;27(5):655-65. doi: 10.1097/01.ftd.0000168293.48226.57.
10
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).重度抑郁症的流行病学:全国共病调查复制研究(NCS-R)结果
JAMA. 2003 Jun 18;289(23):3095-105. doi: 10.1001/jama.289.23.3095.